Oxana Alexandrovna Melkozerova

Dr. Oxana Alexandrovna Melkozerova


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2014 in Gynecological Endocrinology
Verified
Journal Article
Closed access
PDF file
NBN. V. Bachmakova
N. V. Bachmakova
ODO. S. Dubrovina
O. S. Dubrovina
TLT. V. Lisovskaya
T. V. Lisovskaya
OMOxana Alexandrovna Melkozerova
Oxana Alexandrovna Melkozerova
EME. N. Maysina
E. N. Maysina
LSL. B. Sentiurina
L. B. Sentiurina
Known factors of the development of ovarian hyperstimulation syndrome (OHSS) are not informative enough, if considered independently. This is confirmed by the absence of initial predictors in cases of severe OHSS and, in contrast, not clinically apparent manifestations in patients seemingly having high risk of this pathology. These circumstances demand investigation of additional prognostic parameters of the OHSS. Purpose: To find out additional OHSS risk factors alongside with the previously known ones in the course of implementation of assisted reproductive technologies (ART) in patients having initial metabolic and hormonal disorders. Investigation data and methods: Retrospective analysis of clinical laboratory and functional parameters of hormonal and metabolic state of 133 women suffering OHSS was held. Classification by Schenker, 1995, was used to detect the diagnosis. Control group consisted of 347 women with the unverified OHSS. Basic and control study groups were similar in age and in number of mild and long protocols of ovarian stimulation held. Results and their discussion: A significant correlation dependence was revealed between the fact of the OHSS development and some indicators of hormonal and metabolic state: HOMA index of insulin resistance; thyroid parameters: thyroid stimulating hormone (TSH), free thyroxine (fT4), thyroid peroxidase antibodies (AbTPO); and level of prolactin. The revealed correlation dependence of the OHSS development on the above parameters allows to use them for determination of the OHSS risk group and taking measures to prevent this complication of the ART.

31 July 2019 in Gynecological Endocrinology
Verified
Journal Article
Open access
OMOxana Alexandrovna Melkozerova
Oxana Alexandrovna Melkozerova
NBN. V. Bashmakova
N. V. Bashmakova
GMG. B. Malgina
G. B. Malgina
EBE. E. Bragina
E. E. Bragina
AMA. A. Michelson
A. A. Michelson
GCG. N. Chistyakova
G. N. Chistyakova
The scanning electron microscopy of the endometrial surface epithelium during the ‘implantation window’ was performed in 119 patients with uterine factor of infertility or recurrent miscarriage due to endometrial hypoplasia. Ultramorphological picture of the surface endometrial epithelium was characterized by aplasia and hypoplasia of pinopodes (67.39%), dense cell – cell contacts (69.53%), heteromorphy of secretory cells (15.22%) in combination with atypia of microenvironment cells (50%) in patients with infertility. The asynchronous development of pinopodes (46.67%) and the absence of intercellular contacts separation during the ‘implantation window’ (84.44%) was observed in patients with recurrent miscarriage. The revealed disturbance determines the mechanisms of the blastocyst adhesion violation and trophoblast invasion in the different stages of implantation in patients with uterine factor of infertility and recurrent miscarriage.

1 December 2020 in Gynecological Endocrinology
Verified
Journal Article
Open access
OMOxana Alexandrovna Melkozerova
Oxana Alexandrovna Melkozerova
ISIrina Shchedrina
Irina Shchedrina
AGAnastasia Gryshkina
Anastasia Gryshkina
NBNadezhda Bashmakova
Nadezhda Bashmakova
GMGalina Malgina
Galina Malgina
GCGuzel Chistyakova
Guzel Chistyakova
Objective To investigate the effect of the ultrasonic energy during MRI-guided high-intensity focused ultrasound ablation (HIFU) of uterine fibroids on molecular and tissue markers of endometrial receptivity in women of reproductive age. Material and methods A prospective cohort study of 60 women of reproductive age was conducted. The main group consisted of 32 patients suffering from the symptomatic course of uterine fibroids who received treatment with HIFU ablation of uterine fibroids. The control group consisted of 28 healthy fertile women examined voluntarily. The endometrium obtained with pipelle biopsy on days 20-22 of the cycle was examined by scanning electron microscopy and immunohistochemistry before and three months after the treatment. The results were processed by the method of variation statistics using the SPSS 22.0. Results The focused ultrasound rays passing through the endometrium did not cause any change in the maturation rate or the state of intercellular contacts. At the same time, a significant increase in the frequency of asynchronous maturation of pinopodia was found to be 14.28% before HIFU versus 50.00% after HIFU; p = .021 and the number of heteromorphic secretory cells 5.88% before HIFU versus 53.33% after HIFU; p = .002 in implantation endometrium. A significant decrease in the stromal expression of CD95(+bright) in the endometrium to the level comparable with control values was observed after HIFU (from 70.22 +/- 9.77 c/s to 48.81 +/- 5.47 c/s; p < .001; the control level - 47.80 +/- 2.13 c/s). The ratio and expression of steroid receptors, proliferation markers, p53-dependent apoptosis and its blockers, regulators and markers of angiogenesis, LIF and LIF-R signaling molecules in the stroma and endometrial glands did not change significantly after treatment. Conclusion This study did not reveal any significant negative effects of HIFU ablation of uterine fibroids on endometrial receptivity in women of reproductive age.

20 September 2023 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
OMOxana Alexandrovna Melkozerova
Oxana Alexandrovna Melkozerova
EBE.P. Braslavskaya
E.P. Braslavskaya
AMA.A. Mikhelson
A.A. Mikhelson
EOE.O. Okulova
E.O. Okulova
MAM.A. Avseenko
M.A. Avseenko
This review analyzed the literature database, including systematic reviews and randomized clinical trials, on the impact of the microbiota of inflammation and the reproductive tract on the progression of external genital endometriosis and new approaches to diagnosis, cases and cases of relapses. The publications of the pubmed, medline, crossref databases in the interval for 2017—2023 were subjected to analysis. The review demonstrates studies on the relationship between intestinal and reproductive tract microbiota imbalance and the progression of endometriosis, which represents a wide range of therapeutic possibilities. The effectiveness of correction of dysbiosis of the intestinal and reproductive tract in the treatment of genital endometriosis with the use of diet therapy, antibacterial and probiotic preparations has been demonstrated. In this regard, the study of the microbiota of the intestine and reproductive tract is a promising tool for the prediction, prevention and treatment of endometriosis.

1 September 2019 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
OMOxana Alexandrovna Melkozerova
Oxana Alexandrovna Melkozerova
BBBashmakova N.V. Bashmakova
Bashmakova N.V. Bashmakova
OOOkulova E.O. Okulova
Okulova E.O. Okulova

25 May 2023 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
OMOxana Alexandrovna Melkozerova
Oxana Alexandrovna Melkozerova
AMA.V. Murzin
A.V. Murzin
NBN.V. Bashmakova
N.V. Bashmakova
GMG.B. Malgina
G.B. Malgina
EDE.G. Deryabina
E.G. Deryabina
AKA.Y. Khramtsova
A.Y. Khramtsova
ВВЕДЕНИЕ Установлено, что беременность, наступившая после применения вспомогательных репродуктивных технологий (ВРТ), значимо чаще сопровождается развитием гестационного сахарного диабета (ГСД), однако влияние ГСД на развитие акушерских и перинатальных осложнений беременности, наступившей после применения ВРТ, до настоящего времени исследовано недостаточно. ЦЕЛЬ ИССЛЕДОВАНИЯ Определить особенности течения беременности, родов и перинатальные исходы у женщин с беременностью, наступившей после применения ВРТ и осложненной ГСД. МАТЕРИАЛ И МЕТОДЫ Проведено обсервационное одноцентровое ретроспективное когортное сплошное исследование, основную группу (n=41) составили пациентки с беременностью, наступившей в результате применения ВРТ, осложненной ГСД. В группу сравнения (n=35) вошли пациентки с беременностью, наступившей в результате ВРТ, без ГСД. Проведен анализ соматического и гинекологического анамнеза, репродуктивной функции, а также проанализированы перинатальные осложнения и исходы беременности в группах наблюдения. РЕЗУЛЬТАТЫ Пациентки с беременностью, наступившей после ВРТ и осложнившейся ГСД, значимо чаще, чем пациентки после применения ВРТ, но без ГСД страдали избыточным весом и ожирением (ИМТ=30,3 (26,0÷32,3) кг/м2 против ИМТ=26,1 (24,3÷30,0) кг/м2; OR 4,96; 1,47—16,92; p=0,007), заболеваниями сердечно-сосудистой системы (OR 3,84; 1,23—11,96; p=0,003), гипотиреозом (OR 5,53; 1,42—21,29; p=0,008) и хроническими болезнями мочевыделительной системы (OR 4,96; 1,47—16,92; p=0,007). К факторам риска развития ГСД у пациенток после применения ВРТ можно отнести пролонгированное применение препаратов прогестерона после 22 недель (OR 14,097; 4,71—42,21; p<0,001), применение программ ЭКО/ИКСИ (OR 2,751; 1,038—7,29; p=0,039). Беременность, наступившая в результате ВРТ и протекающая на фоне ГСД, значимо чаще, чем беременность после ВРТ без ГСД, осложнялась развитием умеренной (OR 1,083; 1,11—77,52; p=0,04) и тяжелой преэклампсии (OR 1,038; 1,08—69,52; p=0,04), формированием макросомии плода (OR 6,05; 1,24—29,541; p=0,023) и развитием послеродового кровотечения (OR 9,27; 1,11—75,21; p=0,016). ВЫВОДЫ Существует определенный синергизм в отношении влияния ГСД и применения методов ВРТ на течение беременности, родов и перинатальные исходы у пациенток с бесплодием. Своевременное выявление клинико-анамнестических факторов риска, ранняя диагностика ГСД и коррекция нарушений углеводного обмена будут способствовать профилактике и снижению частоты акушерских и перинатальных осложнений у пациенток после применения программ ВРТ.